KorMedi
  • Beauty
  • Health
  • Lifestyle
  • Medicine
  • Biowatch
  • Column
  • Kormedi.com TV
  • Notice
KorMedi
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice

Search results for "ulcerative colitis"

Home
Target the Core: Why 'Deep Remission' Is the New Gold Standard in Inflammatory Bowel Disease Treatment

Target the Core: Why 'Deep Remission' Is the New Gold Standard in Inflammatory Bowel Disease Treatment

Treatment for inflammatory bowel disease is rapidly moving beyond simple symptom management toward the structural restoration of the intestinal...
07/06/2026, 00:30 ET
When Recurrent Diarrhea Is More Than a Passing Bug: The Rising Threat of IBD in Young Adults

When Recurrent Diarrhea Is More Than a Passing Bug: The Rising Threat of IBD in Young Adults

When recurring abdominal pain and diarrhea strike, most people first assume they are dealing with a standard bout of gastroenteritis or irritable...
05/20/2026, 21:00 ET
Celltrion Secures South Korean Phase 1 Approval for Tremfya Biosimilar CT-P68

Celltrion Secures South Korean Phase 1 Approval for Tremfya Biosimilar CT-P68

Celltrion announced on July 15 that it has received approval from South Korea’s Ministry of Food and Drug Safety for an...
07/16/2026, 04:14 ET
1
KorMedi
  • Business registration number: 214-87-97051
  • Press registration number: Seoul A 00292
  • Registration date: 2006-11-30
  • Title: Kormedi.com
  • Representative number: 02-2052-8200
  • Address: 41, Mapo-daero 4da-gil, Mapo-gu, Seoul, Henkel Tower (2nd Floor, Mapo Tower)
  • Issue date: November 30, 2006
  • Publisher and Editor-in-Chief: Seong Ju Lee
  • Youth Protection Officer: Simon Hong
  • Company Introduction
  • Privacy Policy
  • Terms of Service
  • Youth Protection Policy
  • Email Collection Refusal
  • Advisory Board
  • Advertising and Partnership Inquiries

Kormedi.com does not provide medical advice, diagnosis or treatment.

Multilingual content on this site is generated using AI-based translation and may contain errors or differences in interpretation. For legal or medical matters, please refer to the original language version.

© 2026 KoreaMedicare. All Rights Reserved.Powered by 팡고링고
Languages

ENGLISH

English (US)

ASIAN

Монгол日本語Tiếng ViệtBahasa Indonesia中文 (简体, 中国大陆)

EUROPEAN

РусскийEspañol (España)Français (France)

MIDDLE_EAST_AFRICA

العربية